These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33824127)

  • 21. An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2.
    Sharma J; Kumar Bhardwaj V; Singh R; Rajendran V; Purohit R; Kumar S
    Food Chem; 2021 Jun; 346():128933. PubMed ID: 33418408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug repositioning to target NSP15 protein on SARS-CoV-2 as possible COVID-19 treatment.
    Sixto-López Y; Martínez-Archundia M
    J Comput Chem; 2021 May; 42(13):897-907. PubMed ID: 33713492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversible and irreversible inhibitors of coronavirus Nsp15 endoribonuclease.
    Chen J; Farraj RA; Limonta D; Tabatabaei Dakhili SA; Kerek EM; Bhattacharya A; Reformat FM; Mabrouk OM; Brigant B; Pfeifer TA; McDermott MT; Ussher JR; Hobman TC; Glover JNM; Hubbard BP
    J Biol Chem; 2023 Nov; 299(11):105341. PubMed ID: 37832873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical Characterization of Emerging SARS-CoV-2 Nsp15 Endoribonuclease Variants.
    Wilson IM; Frazier MN; Li JL; Randall TA; Stanley RE
    J Mol Biol; 2022 Oct; 434(20):167796. PubMed ID: 35995266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigallocatechin Gallate Inhibits the Uridylate-Specific Endoribonuclease Nsp15 and Efficiently Neutralizes the SARS-CoV-2 Strain.
    Hong S; Seo SH; Woo SJ; Kwon Y; Song M; Ha NC
    J Agric Food Chem; 2021 Jun; 69(21):5948-5954. PubMed ID: 34015930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Efficacious Benefit of 25-Hydroxy Vitamin D to Prevent COVID-19: An In-Silico Study Targeting SARS-CoV-2 Spike Protein.
    Joseph TM; Suresh AM; Kar Mahapatra D; Haponiuk J; Thomas S
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36500994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19.
    Chandra A; Gurjar V; Qamar I; Singh N
    J Biomol Struct Dyn; 2021 Aug; 39(12):4201-4211. PubMed ID: 32462970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reporting dinaciclib and theodrenaline as a multitargeted inhibitor against SARS-CoV-2: an
    Ahmad S; Pasha Km M; Raza K; Rafeeq MM; Habib AH; Eswaran M; Yadav MK
    J Biomol Struct Dyn; 2023 Jun; 41(9):4013-4023. PubMed ID: 35451934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Betulonic Acid Derivatives Interfering with Human Coronavirus 229E Replication via the nsp15 Endoribonuclease.
    Stevaert A; Krasniqi B; Van Loy B; Nguyen T; Thomas J; Vandeput J; Jochmans D; Thiel V; Dijkman R; Dehaen W; Voet A; Naesens L
    J Med Chem; 2021 May; 64(9):5632-5644. PubMed ID: 33877845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based drug designing towards the identification of potential anti-viral for COVID-19 by targeting endoribonuclease NSP15.
    Krishnan DA; Sangeetha G; Vajravijayan S; Nandhagopal N; Gunasekaran K
    Inform Med Unlocked; 2020; 20():100392. PubMed ID: 32835078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flipped over U: structural basis for dsRNA cleavage by the SARS-CoV-2 endoribonuclease.
    Frazier MN; Wilson IM; Krahn JM; Butay KJ; Dillard LB; Borgnia MJ; Stanley RE
    Nucleic Acids Res; 2022 Aug; 50(14):8290-8301. PubMed ID: 35801916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The coronavirus endoribonuclease Nsp15 interacts with retinoblastoma tumor suppressor protein.
    Bhardwaj K; Liu P; Leibowitz JL; Kao CC
    J Virol; 2012 Apr; 86(8):4294-304. PubMed ID: 22301153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of SARS2 Nsp15 nuclease activity reveals it's mad about U.
    Frazier MN; Dillard LB; Krahn JM; Perera L; Williams JG; Wilson IM; Stewart ZD; Pillon MC; Deterding LJ; Borgnia MJ; Stanley RE
    Nucleic Acids Res; 2021 Sep; 49(17):10136-10149. PubMed ID: 34403466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Situ Tagged nsp15 Reveals Interactions with Coronavirus Replication/Transcription Complex-Associated Proteins.
    Athmer J; Fehr AR; Grunewald M; Smith EC; Denison MR; Perlman S
    mBio; 2017 Jan; 8(1):. PubMed ID: 28143984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an
    Mahmud S; Elfiky AA; Amin A; Mohanto SC; Rahman E; Acharjee UK; Saleh A
    Future Virol; 2021 Jun; ():. PubMed ID: 34290822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling.
    Otter CJ; Bracci N; Parenti NA; Ye C; Asthana A; Blomqvist EK; Tan LH; Pfannenstiel JJ; Jackson N; Fehr AR; Silverman RH; Burke JM; Cohen NA; Martinez-Sobrido L; Weiss SR
    Proc Natl Acad Sci U S A; 2024 Apr; 121(15):e2320194121. PubMed ID: 38568967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization Rules for SARS-CoV-2 M
    Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotic-Induced Primary Biles Inhibit SARS-CoV-2 Endoribonuclease Nsp15 Activity in Mouse Gut.
    Ma Y; Luo M; Deng Y; Yang X; Wang X; Chen G; Qin Z; Deng Y; Nan M; Chen Y; Wang P; Wei H; Han L; Fang X; Liu Z
    Front Cell Infect Microbiol; 2022; 12():896504. PubMed ID: 35967852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of bioactive compounds from
    Sinha SK; Prasad SK; Islam MA; Gurav SS; Patil RB; AlFaris NA; Aldayel TS; AlKehayez NM; Wabaidur SM; Shakya A
    J Biomol Struct Dyn; 2021 Aug; 39(13):4686-4700. PubMed ID: 32552462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.